Proficio Capital Partners LLC Acquires 6,000 Shares of iShares NASDAQ Biotechnology Index (IBB)

Proficio Capital Partners LLC grew its holdings in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 181.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,300 shares of the financial services provider’s stock after acquiring an additional 6,000 shares during the period. Proficio Capital Partners LLC’s holdings in iShares NASDAQ Biotechnology Index were worth $993,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. FNY Partners Fund LP bought a new stake in iShares NASDAQ Biotechnology Index in the third quarter worth approximately $133,000. Wharton Business Group LLC bought a new stake in iShares NASDAQ Biotechnology Index in the third quarter worth approximately $208,000. New England Investment & Retirement Group Inc. bought a new stake in iShares NASDAQ Biotechnology Index in the third quarter worth approximately $213,000. Leavell Investment Management Inc. bought a new stake in iShares NASDAQ Biotechnology Index in the third quarter worth approximately $214,000. Finally, Fishman Jay A Ltd. MI bought a new stake in iShares NASDAQ Biotechnology Index in the third quarter worth approximately $247,000. 38.31% of the stock is owned by institutional investors.

Shares of iShares NASDAQ Biotechnology Index (IBB) opened at $110.36 on Monday. iShares NASDAQ Biotechnology Index has a 1 year low of $94.20 and a 1 year high of $119.30.

WARNING: “Proficio Capital Partners LLC Acquires 6,000 Shares of iShares NASDAQ Biotechnology Index (IBB)” was reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://stocknewstimes.com/2018/02/19/proficio-capital-partners-llc-acquires-6000-shares-of-ishares-nasdaq-biotechnology-index-ibb.html.

iShares NASDAQ Biotechnology Index Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares NASDAQ Biotechnology Index (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply